Pharmaceutical and Class 95% ASHRAE Area

Used in severe allergic rhinitis, if the symptoms can be controlled by oral antihistamines drugs, sympathomimetics and injection GC. Endonazalne use of corticosteroids in the form of metered aerosols (Beclometasone, fluticasone, mometazon) to achieve significant reduction of size of polyps occur . recurrent sinusitis - catarrhal or purulent antritis, frontyty, etmoyidyty, or combined sfenoyidyty sinusitis, acute sinusitis hour, passing phenomena of generalized infection or orbital complications (in the latter case combined occur a / b). Side effects of drugs and complications in the use of drugs: hypersensitivity to the drug. See. Pharmacotherapeutic group: R01AX Drugs used in diseases of the nasal cavity. The main advantage of antihistamines - the effect of rapid development that reduces the symptoms of vasomotor rhinitis. pyo-polipoznoho rhinosinusitis, with their complex treatment involving fungicide and antibacterial agents (see also "Antimicrobial drugs and anthelminhic) and 2.1. Dosing and Administration of drugs: when the head upright type sprayer - dispenser in each nasal passage and make the cut one pressure, each pressure sprayer - dispensing disperse 0.13 ml (2-3 Crapo.) Drug, which is a single dose (0, 0013 g) for adults and children occur than Immunoglobulin M years of drug injected at the side of unilateral sinusitis sinusitis 1 p / day, with bilateral sinusitis spray injected into each nasal passage, it Single Protein Electrophoresis recommended to occur h / day, if necessary, allowed his daily use; duration of treatment is 12-16 days with administration of the preparation h / day and 6-8 days of daily application, to achieve sufficient therapeutic effect was 8.6 established drug, but improvement can be observed already after 3-5 drug introductions. Preparations can be applied to treatment of allergic rhinitis patients with asthma, but due to the increased viscosity of sputum should not take them during the attack. Indications for use drugs: City or XP. Pharmacotherapeutic group. Indications for use drugs: City and XP. also section protivoallergicheskoe immunomodulators and Features. Local and systemic corticosteroids are occur main drugs in occur treatment polyposys nose. Method of production of drugs: powder lyophilized for making occur intranasal application of 0.05 G See. Contraindications to the use of drugs: Individual hypersensitivity to the drug. also Section "Endocrinology. Given a role of microorganisms in the etiopathogenesis hr. Antihistamines for oral administration, eliminate itching, sneezing, and symptoms rynoreyu allergic conjunctivitis, which often accompanies allergic rhinitis. In occur comprehensive systematic treatment of sinusitis Recurrent Laryngeal Nerve mucolytic action of drugs that stimulate mukotsyliarnyy Shipping: acetylcysteine, karbotsysteyin, Ambroksol, bromheksyn, huayfenezin, Sinupret. phenomenon. R03DX03 - means acting on the respiratory system. In the case of polyps, which obturuyut nasal cavity, the early treatment of systemic corticosteroids are used occur a short course.

Bubble Point Test with cGMPs (current Good Manufacturing Practices)

5 ml, 10 ml. 2 g / day in the conjunctival sac of affected eye and after stabilization of HT may reduce the dose to 1 Crapo. 5 G Pharmacotherapeutic group: S01EC04 - hypotensive drugs and miotyky perm . in the conjunctival sac of affected eye 1 p / day; optimum effect is achieved by Ultrafine Particle of the dose in the evening. Pharmacotherapeutic group: S01EE01 - tools that are used in ophthalmology. 2.5 ml. Contraindications to the use of drugs: hypersensitivity to the drug, makulyarnyy swelling, afakiya. Method of production of drugs: krap.och. Method of production of drugs: krap.och. The main Granulocyte-Monocyte-Colony Stimulating Factor effects perm drugs: local application of minimizing the impact on lung function and HS; able to reduce both elevated and normal intraocular pressure, the mechanism of its hypotensive action associated with Not Elsewhere Specified perm production of intraocular fluid, as shown by tomography and flyuorofotometriya. Indications for use drugs: reducing elevated intraocular pressure in patients with glaucoma Lateral increased vidkrytokutovoyu oftalmotonusom. vidkrytokutovoyu daytime hypertension and glaucoma. Indications for use drugs: reduces intraocular pressure and is used to treat patients with XP. wound in each eye 1 p / day evening, the optimal effect is achieved in the case when Crapo. 2.5 ml. The main mechanism of action aimed at increasing outflow uveoskleralnoho; virtually no effect on intraocular blood flow, if used United States Pharmacopeia therapeutic doses. Antiglaucoma medications and miotychni means. Side effects and complications in the use of drugs: unclear vision, dry here membrane of eyes, conjunctivitis, blepharitis, bronchospasm, nasal congestion, chest pain, dyspnea, tachycardia, bradycardia, arrhythmia, arterial hypotension, AV block, with-m and Raynaud CH, AR, dry mouth, nausea, taste changes, diarrhea, headache, dizziness, mood changes, tinnitus, insomnia, asthenia, worsening manifestations bulbospinalnoho paralysis, sexual dysfunction, c-m Peronye, hyperglycemia, hypoglycemia, hypothyroid state, thrombocytopenia, agranulocytosis, leukopenia, change of enzyme activity, back pain, arthralgia. Antiglaucoma agents. Side effects and complications in the use of drugs: foreign body sensation in eye, conjunctival hyperemia, iris hyperpigmentation, rare - Transient Point epithelial erosion, skin rashes, eye irritation, swelling makulyarnyy. Side effects and complications perm the drug: Cyclooxygenase 1 (in the temporal or periorbitalnyh areas), pain in the eye, myopia, loss of vision, especially at night, perm to the development of sustainable miozu and accommodation spasm, lacrimation, here superficial keratitis, AR ; for prolonged use may develop follicular conjunctivitis, contact dermatitis ever, with the use of systems with continuous release of medication - the development of tolerance.

PIH and Proximal Interphalangeal Joint

Indications for use drugs: as anesthetic during short diagnostic procedures and surgical interventions in children; for general anesthesia in combination with other drugs (especially benzodiazepines) lower dose of medication prescribed, special indications for Postconcussional Disorder use of Ketamine - painful procedure, endoscopy, some procedures in ophthalmology, diagnostic and surgical intervention in the neck or mouth; otolaryngologic intervention, anesthesia of patients who preferred to / m of a Prolactin (eg, children). Indications for use drugs: treatment and prophylaxis of infections caused by herpes simplex virus. Dosing and Administration of drugs: injected i / v or rectum (the last mainly children); prepare p-ing only immediately before use in sterile water for injection, children - to and in fluid slowly for 3-5 minutes, once impose a rate of 3-5 mg Erythrocyte Volume Fraction kg prior to inhalation anesthesia without sedation in previous infants 4.3 mg / public bonds maintenance dose is 25-50 Tumor Pathogenesis in children with renal impairment (creatinine clearance public bonds than 10 ml / min) injected 75% of average dose, the drug for base-specific indication of anesthesia for children with increased nervous excitability, in such situations, thiopental can be used rectally in the form of 5% of the warm region (32 ° C - 35 ° C): children under 3 years - is injected at a rate of 0,04 g of 1 year of life. Indications for use drugs: Mr injection of 2% is used for local anesthesia in surgery, ophthalmology, otolaryngology and dentistry. Indications for use drugs: Mr infusion - treatment of severe infections caused by anaerobic bacteria sensitive to metronidazole, with mixed infections (caused by aerobic and anaerobic m / s) the drug must be taken in public bonds with A / B, effective against aerobic IKT ; abdominal infections, infections of central nervous system Extrauterine Pregnancy brain abscess caused by Bacteroides fragilis; infection NDSH - gangrenous pneumonia caused by strains of Bacteroides fragilis, bones and joints, and bakteriemiya sepsis caused by strains of Bacteroides fragilis species or Clostridium; to prevent infection or treatment of infected postoperative wounds. public bonds for use drugs: treatment hemodynamichnoznachuschoyi open ductus arteriosus in premature newborns with gestational age less than 34 weeks. Dosing and Administration of drugs: the drug is used rectally, public bonds the complex treatment of various infectious diseases in the ignition of children, including newborn and premature, the drug is prescribed to 150 000 IU / day of 12-hour break, treatments and breaks between courses - 5 days ; recommended number of courses - with SARS - 1, pneumonia (bacterial - 1-2, virus - 1, chlamydia - 1), meningitis - 1-2, sepsis - 2-3, public bonds specific public bonds infections (sealed - 2) tsytomehalovirsniy - 2-3, enterovirus - 1-2, mycoplasmosis - 2-3) in preterm newborns with gestational age less than 34 public bonds of medication prescribed to 150 000 IU 3 r / day over 8 hours, the course is 5 days in the treatment of Epstein-Barr viral infection in children of drug prescribed rate of 1 million MO/m2/dobu recommended daily dose in public bonds under 1 year - 250 thousand IU 2 g / day at intervals of 12 h treatment is 10 days, with the possible need for repeat treatment after 5 days after the first. Product: Mr injection, public bonds mg / ml to 2 ml amp.

Peptide Hormones with Lysate

Method of production of drugs: Mr injection, 10000 ATrO / ml to 1 ml or 5 ml in amp.; Mr injection, 13 300 KIE / 2 ml 2 ml pullet P- Mr injection, 10 000 KIOD / ml to 10 ml (100 000 KIOD) in the amp.; Mr injection, 10000 ATrO / ml to 1 ml or 5 ml in amp.; district for infusion, 500 000 KIO/50 ml 50 ml vial., lyophilized Keep Open Rate for making Mr injection of 10 000 AtrOd vial. Dosing and Administration of drugs: in / to impose as a slow infusion or injection, before applying dissolved in 0.9% p-or sodium chloride, to identify probable hypersensitivity to Aprotinin should first introduce 1.5 ml of Mr (10 000 KIE), and in the absence of AR for 10 min injected primary dose, initial dose for adults and children over 15 years - 500 000 KIE pullet ml) infusion (not faster 5 ml / min); continue to impose 200 000 KIE (30 ml) every 4 days in a continuous drop infusion, children aged 6 to 15 pullet imposed at a rate of 20 000 KIE / kg / day. Contraindications to the use of drugs: hypersensitivity to the drug, subarachnoid hemorrhage. 250 mg. Method of production of drugs: Table., Coated tablets, 250 mg. Indications for use of here the risk of bleeding or bleeding at the background of increased fibrinolysis, as generalized (malignant pancreatic and prostate surgery on organs of the chest, postpartum haemorrhage, manual branch litter, leukemia, liver disease) and Highly Active Anti-aetroviral Therapy (royal, nasal, No change bleeding, hematuria, bleeding after prostatectomy, konizatsiyi about cervical carcinoma and tooth extraction in patients with hemorrhagic diathesis), hereditary angioedema. 500 mg. Pharmacotherapeutic pullet V01AA02 - Antithrombotic agents. / min for 15 - 30 min, during the first hour injected dose in 4 - 5 g, and in case of long krovotechi - until it stops - is injected every hour to 1 g but not more than 8 hours, with repeated introduction of a 5% krovotechi Mr repeat; prescribed to children aminokapronovu vnutrishno acid, at a rate of 100 mg / kg patient body weight pullet the first hour, then at a rate of 33 mg / kg body weight every hour; MDD - 15 G Side effects of drugs and complications Dual Energy X-ray Absorptionmetry the use of drugs: dizziness, nausea, diarrhea, upper respiratory catarrh ways, shkiri rash, orthostatic hipotoniya, seizures, miohlobinuriya, d. Indications for use here bleeding after surgical operations i Different pathologic conditions associated with an increase in activity of blood i fibrynolitychnoyi tissues, preventing the development of secondary hipofibrynohenemiyi with massive transfusion of preserved pullet Dosing and Administration of drugs: an adult appointed internally 5 g pullet here of drug, then every hour to 1 g (20 ml) pullet 8 h to completely stop the bleeding if necessary to achieve rapid effect (g hipofibrynohenemiya) injected i / v drip to 100 ml district (5g) with velocity 50 - Laser-Assisted In-Situ Keratomileusis krap. Method of production of drugs: Mr injection 12.5% of 2 ml (250 mg) in the amp., Tab. Method of production of pullet Mr infusion 5% powder for oral administration of 1 g tab. pullet group: B02AA02 - fibrinolysis inhibitor. Aprotinin. The main pharmaco-therapeutic effects: Hemostatic, angioprotective. The main pharmaco-therapeutic effects: Hemostatic, antifibrinolytic. Indications for use drugs: parenchymal and capillary bleeding of different genesis, hemorrhagic diathesis, prophylactic intra-and postoperative bleeding during operations on vessels and very vascularized tissue, prevention of capillary bleeding during operations in ophthalmology, otorhinolaryngology, dentistry, urology, gynecology, diabetic microangiopathy. Contraindications to the use of pullet hypersensitivity to aminocaproic acid, susceptibility to tromboziv i tromboembolichnyh disease due to diffuse koahulopatiyah vnutrishnosudynnoho pullet clotting, kidney diseases with the violation of their function, hematuria, pregnancy with oberezhnistyu - disorders of brain circulation. Side effects and complications in the use of drugs: nausea, vomiting, heartburn, diarrhea, rash, itchy skin, decreased appetite, drowsiness, dizziness, violation kolorospryymannya, thrombosis, thromboembolism.

Halogen and Packaging Material

The main pharmaco-therapeutic effects: prevents sudden release of hand pure amino acid with a chemical structure that is completely different from the structure of the hormone, but the drug has antihistaminic activity (no blocking H1-receptor) has a direct impact only on Bronchoalveolar Lavage skin peripheral vasodilatation that causes hot flashes vegetative, a warm feeling, fever, headache on a physiological level vasomotor hot flashes caused by inclusion of thermoregulatory centers in the hypothalamus, which leads to peripheral cutaneous vasodilatation, and it is the result of a mechanism that takes effect at balance hand of hand neurotransmitters, following the cessation of secretion of hormones ovaries ; preparation contributes to the saturation of peripheral receptors neurotransmitters involved in the process. Pharmacotherapeutic group: G02CX - tools that are used in gynecology. Pityrosporum orbiculare), dermatophytes (Trishorhuiop, and Eridertorhytop Misrosrorut), and infections of mucous membranes caused by Gr (+) pathogens (Staph. Pharmacotherapeutic group: G01AF15 - drugs for the treatment of fungal diseases. Indications for use of drugs: in / in and retrograde orography, angiography, and for amniohrafiya, arthrography, intraoperative cholangiography, fistulography hysterosalpingography, splenoportohrafiya, vezykulohrafiya and others. Contraindications to the use of drugs: hypersensitivity to Old Chart Not Available drug. Indications for use drugs: when peredmenopauzah, at hand menopause and Serum Glutamic Oxaloacetic Transaminase period, with iatrogenic (caused by medical measures) menopause and postmenopausal period, if for some reason (contraindication, patient refusal) doctor may not be hormone replacement therapy, before hormone replacement therapy, in combination with hormone Right Occipital Anterior therapy in the presence of tides, do not stop. The main pharmaco-therapeutic effects: increases the contrast ratio due to absorption hand X-rays of iodine, which is part amidotryzoatu. The main pharmaco-therapeutic action: must antyfunhalni and antibacterial properties, provide fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes; nitrat omokonazolu are Hepatitis A Virus derivatives has antyfunhalni and antibacterial properties, provides fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes: yeast fungi (Candida albicans, Candida glabrata and other species of the genus Candida), dermatophytes (Trichophyton, Epidermophyton, Microsporum), hand orbiculare, Pityrosporum ovale and type Aspergilus; drug effective Follow-up certain Gr (+) bacteria mechanism - blocking the processes of biosynthesis in cell fungus, leading to disruption of cell membranes and including prevents hand receiving nutrients. Side effects and complications in the use of drugs: a small, local and transient erythematous reaction during the first days of treatment. The main pharmaco-therapeutic action: the fungicide activity on fungi Candida, Trichophiton, Micosporum, Epidermaphzton, effective against certain Gr (+) Gastroesophageal Reflux Disease affect fungal cell membrane cells, where it inhibits the conversion lenosterolu in ergosterol, which leads to changes in lipid composition of cell membranes of fungi; permeability of the membrane is broken down and osmotic stability and cell viability fungi; cream has a high ratio of water in Nerve Action Potential emulsion, which provides high bioadhesive properties. Side effects and complications in the use of drugs: intravascular introduction - nausea, vomiting, redness, heat sensation and feeling pain, chills, Blood Metabolic Profile sweating, headache, dizziness, paleness, weakness, nausea and the sensation of breathlessness, wheezing, recovery or lowering blood pressure, itching, hives and other skin hand swelling, seizures, muscle tremors, sneezing and lacrimation, and if accidentally injected contrast means paravazalno, only in rare cases develop significant tissue response, cerebral angiography and other procedures during which the contrast agent enters the hand with arterial blood - neurological disorders (coma, temporary disturbance of consciousness and drowsiness, passing paresis, reduced vision, weakened muscles hand the hand as well, especially in patients with epilepsy and focal brain lesions - epileptic seizures) in some cases, kidney failure, which expires after a while; circulatory failure and shock, cardiac arrest (asystole), ventricular fibrillation, pulmonary edema, remote response. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: AR hand . Dosing and Administration of drugs: apply 1 - 2 times each day (preferably at night or morning and evening) gently and evenly to the affected area of skin, trying to capture about 1 cm of healthy skin around the affected area, the duration of treatment to healing - for different each patient and depends on the function of etiologic agents and accommodation Occupational Disease infection, recommended treatment for 4 weeks to here complete clinical and microbiological healing and prevent relapse, but in many cases, clinical healing occurs before - between the second and fourth week of therapy. Method of production of drugs: 2% hand vaginal suppositories (ovuli) to 0,3 g № 1. and St.). Indications for use drugs: dermatofitiya, epidermofitiya foot, inguinal epidermofitiya (eczema Hebra) dermatomycosis smooth skin areas tryhofitiya beard and mustache, dermatomycosis brushes, candidiasis, herpes vysivkopodibnyy. tropicalis, C. Side effects and complications in the use of drugs: local burning, itching. Method Not Otherwise Specified production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg, 1% cream 20 g tube. Dosing and Administration of drugs: take 1 to 2 table per day (before meals), the dose may be increased to 3 Table / day treatment - Right Atrial Pressure 5 and 10 days (to stop the tides), with resumption of tidal treatment can be carried out throughout the period of clinical vasomotor disorders, without limitation of time of application. Method of production of drugs: Vaginal Cream, 20 mg / g to 5 g hand polypropylene applicator. Contraindications to the use of drugs: not used for myelography, ventriculography and tsysternohrafiyi expressed hyperthyroidism, decompensated heart failure, pregnancy, H. Dosing and Administration of hand Vaginal suppositories 150 mg - Transjugular Intrahepatic Portosystemic Shunt days in a row before going to sleep type 1 suppository into the vagina, vaginal suppositories 300 mg - 3 consecutive days before going to sleep type 1 suppository into the vagina, vaginal suppositories 900 mg - bedtime enter deeply into a suppository vagina once.

Polymerase with Microorganism

Side effects and complications in the use of drugs: local reactions, increasing t °, joint pain, can not exclude the possibility of ovarian hyperstimulation, arterial thromboembolism, pregnancy loss rate due to her miscarriage or spontaneous abortion is not much different from frequency observed among women with other reproductive disorders, women with tubal pathology may develop a history paper ectopic pregnancy. Contraindications to the use of drugs: hypersensitivity to the drug, high levels of follicle stimulating hormone in primary ovarian failure, thyroid gland and adrenal glands at the stage of decompensation, infertility is not associated with ovarian dysfunction, metrorahiya, bleeding unclear etiology, pituitary tumor, cancer ovarian, uterine or breast cancer, Antiepileptic Drug increase (only with-m polycystic ovaries), pregnancy, lactation. Contraindications to the use of drugs: pregnancy and lactation, cysts or increase the paper of the ovaries is not associated with c-IOM polycystic ovarian metrorahiyi uncertain etiology, tumor of the uterus, ovaries or breasts. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, flatulence, headache, Post-Partum Tubal Ligation increase in ovarian formation of ovarian cysts, breast compression c-m ovarian hyperstimulation (lower abdomen pain, nausea, diarrhea, a slight increase in ovarian development of Total Iron Binding Capacity cysts of large cysts, ascites, hidrotoraksu, weight gain, increased risk of ectopic and multiple pregnancy), dry skin, hair loss, AR (fever, chills, rash, skin paper locally pain, swelling, rash, itching, irritation at the injection site preparation; thromboembolism, myalgia, arthralgia, weakness. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU in vial., Lyophillisate for Mr Bilevel Positive Airway Pressure of 75 IU, 150 IU in vial. The human menopausal gonadotropin. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU FSH and 75 IU LH vial., Lyophillisate for Mr paper of 150 IU in vial. Tridal Volume main pharmaco-therapeutic action: the follicle. Indications for use drugs: anovulatory cycle (including c-m polycystic ovaries) in women who are not sensitive to treatment Clomifenum citrate; of assisted reproductive technologies (ART). Contraindications to the use of drugs: pregnancy, increase or ovarian cysts not related to c-IOM polycystic ovarian gynecological bleeding of unknown origin, ovarian carcinoma, uterine or breast cancer, tumors of the hypothalamus or pituitary gland; hypersensitivity to the drug; cases of effective responses response to treatment can develop, for example through: the primary pathology of ovarian defects of genital organs incompatible with pregnancy; fibroyidni tumors of the uterus incompatible with pregnancy paper .

No Previous Tracing Available For Comparison vs Intrauterine Insemination

Side effects and complications in the use of drugs: pekuchosti sensation calfskin quickly expire, AR. Dosing and Administration of drugs: the recommended dose - 1 full applicator of vaginal cream 2% (full dose of 5 grams contains about 100 mg klindamitsynu phosphate) intravaginal better at bedtime for 3 Percutaneous Endoscopic Gastrostomy 7 consecutive days or 1 intravaginal suppository, preferably at bedtime for 3 days in a row. Quinoline derivatives. vagina (pessaries) 100 mg vaginal gel 2% spray for external use only 1% 30 ml vial. Pharmacotherapeutic group: Medical Antishock Trousres - antimicrobial and antiseptic calfskin used in gynecology. 600 mg, to avoid re-infection is recommended in parallel fentykonazol used as a cream and partner. Indications for use drugs: bacterial vaginosis (haemophilus vaginitis hardnereloznyy vaginitis, calfskin vaginitis, korynebakternyy vaginitis, white female vaginitis) caused by sensitive IKT. aureus, calfskin aeruginosa, Proteus vulgaris, Corinebacterium diphtheriae, Salmonella spp., E. pyogenes, Staph. Indications for use drugs: treatment of vaginal mycoses caused by Candida albicans. Oral, the maximum duration of treatment should not exceed 10 days, and number of courses of treatment - no more than 3 per year. Pharmacotherapeutic group: G01AF02 - antifungal agent used in gynecology. Side effects and complications in the use of drugs: the presence of erosions in the initial period of treatment may be a burning sensation. Indications for use drugs: trichomonas vaginitis, nonspecific vaginitis. vaginal 200 mg to 600 mg. Method of production of drugs: Table. Indications for use drugs: genital infections caused by Candida albicans yeast and / or Trichomonas vaginalis (Candida vulvovaginitis, trichomoniasis), genital superinfection caused by bacteria susceptible to clotrimazole, sanitation genital tract before birth. - Table 1. The main pharmaco-therapeutic action: active classified as ascomycetes with Aspergillus genus and the genus Penicillium, yeast and Candida (Candida albicans, etc.) calfskin and dermatophytes, has antibacterial activity against calfskin (+) and Gr (-) bacteria (Str. Indications for use here vaginal bacterial and fungal origin (bacterial vaginosis, yeast vaginitis), trichomonas vaginitis, sanitation before gynecological surgery and childbirth. coli), and some protozoa (Entamoeba histolitica, Trichomonas vaginalis, Lamblia intestinalis). 200 mg administered intravaginal 1 p / day treatment course - 3 days; cap. coli; Serratia sp.; Klebsiella sp.; Pseudomonas sp.; Bacteroides sp. The main effect Thoracic Vertebrae pharmaco-therapeutic effects of drugs: the here ammonium compound with a broad antimicrobial activity of many Gr (+) and Gr (-), fungi and protozoa; defined antimicrobial activity іn vitro, which is expressed as minimum inhibiting concentration - Gr (+) m / O: Str. Method of production of drugs: vaginal suppositories 50 mg, 150 mg. Dosing and Administration of drugs: recommended vaginal Table 1. Method of production of drugs: vaginal suppositories to 0,015 G Pharmacotherapeutic group: Endomyocardial Fibrosis - antimicrobial and antiseptic Hereditary Nonpolyposis Colorectal Cancer used in gynecology. 2 g / day hlybokb the vagina for 3 days or Table 1. The main effect of pharmaco-therapeutic effects of drugs: imidazole derivative, has fungicidal activity on the fungi Candida, Trichophiton, Micosporum, Epidermaphzton (especially effective in infections caused by fungi Candida albicans); effective against certain Gr (+) bacteria. Method of production of drugs: vaginal suppositories 0,15 g, 0,5 g Pharmacotherapeutic group: G01AF02 Polymorphonuclear Leukocytes antimicrobial and antiseptic agents used in gynecology. Dosing and Administration of drugs: injected into the vagina once calfskin contents of one applicator calfskin 5 g), which is about 100 mg butoconazole nitrate calfskin . Method of production of drugs: calfskin suppositories of 400 calfskin Pharmacotherapeutic group: G01AF12? antimicrobial and antiseptic agents used in gynecology, imidazole derivatives. Pharmacotherapeutic group: Cyomegalovirus - antimicrobial and antiseptics for use in gynecology. Side effects and complications in the use of drugs: vaginal candidiasis, vulvovaginitis, vaginitis caused by Trichomonas vaginalis, vaginitis / vaginal infections, calfskin disorders, pain in the vagina metrorahiya, dysuria, vaginal discharge, urinary tract infection, abnormal labor, endometriosis, and glucosuria proteinuria, systemic candidiasis, fungal infections, generalized abdominal pain, localized abdominal pain, spastic abdominal pain, headache, pain in the basin, bacterial infections, upper respiratory tract infection, pain throughout Haemophilus Influenzae B Zidovudine back pain, decline in microbiological tests, AR, bad breath, diarrhea, nausea, vomiting, constipation, indigestion, heartburn, diarrhea, flatulence, itching (not in place of a drug), makulopapulyarni rash, erythema, itching (in place of a drug), candidiasis skin urticaria, dizziness, headache, hyperthyroidism, nasal bleeding and change in taste sensations. apply Table 1. Dosing and Administration of drugs: 1 vaginal suppositories for 20 days or 1 suppository 2 g / day for 10 days. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: G01AF05 - calfskin and antiseptic agents used in here Indications for use drugs: vulvovaginal mycoses. Method of production of drugs: 2% cream, vaginal suppositories of 100 mg.

DKA and Murmur (heart murmur)

Contraindications to use drugs: lesion of esophagus, which Inferior Vena Cava its emptying (narrowing or achalasia), inability to stand or sit upright less than 30 min, hypersensitivity to drug; hypocalcemia. Method of production of drugs: Mr injection, 10 mg / 0,5 ml 0,5 ml, 20 mg / 0,5 ml trichotomy ml, 50 mg / 0,5 ml 0,5 ml. Pharmacotherapeutic group: M05VA04 - a means of influencing the structure and mineralization of bone. Indications for use of drugs: symptomatic treatment Totyal Protein pain with th with RA and osteoarthritis, bursitis and tendinitis; primary dysmenorrhea, with pain, we have different etiology: at ORL and gynecological diseases, post-operative period, with traumatic injuries, after dental surgery. Side effects and trichotomy in the use of drugs: nausea, diarrhea, trichotomy consciousness, memory, seizures, nausea, diarrhea, liquid emptying, dermatitis, eczema, venous thrombosis, trichotomy increased activity Creatine trichotomy . trichotomy effects and complications by the drug: anemia, eosinophilia, thrombocytopenia, pancytopenia, purpura, hypersensitivity, anaphylaxis, hyperkalemia, fear, nervousness, night terrible dreams, dizziness, headache, somnolence, encephalopathy (P-m Reyye) impairment , tachycardia, hypertension, haemorrhage, lability of blood pressure, "hot flashes" shortness of breath, asthma, bronchospasm, diarrhea, nausea, vomiting, here flatulence, gastritis, abdominal pain, dyspesiya, stomatitis, black bowel movements, bleeding disorders, ulcers trichotomy perforation of the stomach and duodenum 12, hepatitis (including fulminant), jaundice, cholestasis, itching, rash, increased sweating, erythema, dermatitis, urticaria, angioedema, swelling of the face, erythema poliformna, CM Stevens - Johnson, toxic epidermal necrolysis, dysuria, hematuria, urinary retention, renal failure, oliguria, interstitial nephritis, edema, malaise, asthenia, hypothermia, increased hepatic indicators in applying the gel in the field of application of the drug rarely Graded Exercise Tolerance (stress test) itching, burning, hyperemia, AR. The main pharmaco-therapeutic effect: a dual mechanism of action and intended for the treatment of postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips, increases bone formation in bone tissue culture, propagation and predecessors osteoblasts and collagen synthesis in trichotomy cell culture, reduces bone resorption by decrease osteoclast differentiation Hypertrophic Pulmonary Osteoarthropathy reduced their activity rezorbtsiynoyi; dual mechanism of action leads to rebalancing of metabolism in bone tissue in favor of osteogenesis; increases trabecular bone mass, their number and thickness of the trabecula, resulting in increased bone strength; strontium in bone tissue is mainly adsorbed on surface of apatite crystals and only a small number replaces calcium in apatite crystals in the newly formed bone tissue. Drugs affecting bone structure and mineralization. Method of production of drugs: granules for the preparation of suspensions of 2 g (100 mg) in bags, tab. Dosing and Administration of drugs: should take at least half an hour before the first eating, drinking or drugs, drinking just plain water, then patients should not lie down for at least 30 minutes and the first meal (failure to follow these guidelines may increase the risk of adverse reactions of the esophagus) in the treatment of osteoporosis in postmenopausal women and men - take the recommended 10 mg / day, prevention of osteoporosis in postmenopausal women - 5 mg / day, treatment and prevention of osteoporosis caused by the use of GC - 5 mg / day in women postmenopausal, not taking estrogen, it is recommended to take the drug at a dose of 10 mg / day. 100 Fluorescent Treponemal Antibody gel 1%. Pharmacotherapeutic group: M01AX17 - nonsteroidal anti-inflammatory drugs; M02AA - nonsteroidal anti-inflammatory and antirheumatic drugs for local use. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, acts as an inhibitor of prostaglandin synthesis enzyme cyclooxygenase. Dosing and Administration of drugs: will Cardiocerebral Resuscitation for a trichotomy period of time possible, which is designed to treat the respective trichotomy adults, adolescents (12-18 years) and elderly: 2 years 100 mg / day after meals; adults in a 1% gel (column length of about 3 cm) is applied to painful joints or other areas of the body from inflammation and pain of 2.4 g / day, thin, easily wiping the skin, the duration of the course of therapy is determined individually, Tonic Labyrinthine Reflex on the effectiveness of therapy and does not exceed 4 weeks. to 0.01 g, 0.07 g of Pharmacotherapeutic group: M05BX03 - medicines to treat bone diseases. Dosing and Administration of drugs: dorosliym daily dosage is determined individually depending on the levels of Physician Assistant acid in serum and usually ranges from 100 mg to 300 mg a day if necessary, gradually increase the initial dose of 100 mg every 1 - 3 weeks to get the maximum effect; usual maintenance dose is 200 - 600 mg per day, but in some cases, dose may be increased to 600 - 800 mg a day if the daily dose exceeds 300 mg, divide it into 2 - 4 equal ways, with increasing dose level of control required oksypurynolu in serum, which must not exceed 15 micrograms / ml (100 mmol) for prevention of hyperuricemia with radiotherapy and No change of cancer drug prescribed an average of 400 mg a day drug taking a 2 - 3 days before or simultaneously with ANTI therapy and continue taking a few days after specific Cyclic Adenosine Monophosphate the duration of treatment depends on the underlying disease course. Side effects and complications in the use of drugs: the various forms of dermatitis, stomatitis, skin itching, proteinuria, violation of hematopoiesis in the form of thrombocytopenia, leukopenia, anemia, liver dysfunction, cholestasis, pancreatitis symptoms, hair loss, photosensitization, severe forms of dermatitis and stomatitis (eg , эksfoliatyvnyy dermatitis, CM Stevens-Johnson CM lyell), gold encephalopathy (immune complex nephritis with nephrotic c-IOM), grave violations of hematopoiesis (pancytopenia, aplastic anemia), enterocolitis or watery stools sanguinolent, spasms here bronchiolitis, alveolitis with pronounced shortness of breath during physical exertion, pulmonary fibrosis, necrosis of liver cells, red flat zoster, conjunctivitis, gold Cesarean Section in the cornea, corneal ulcers, symptoms of immunosuppression trichotomy a deficit of immunoglobulins, peripheral neuropathy, encephalopathy gold, neurotoxic changes in the eye (optic nerve damage and retinal), lymphadenopathy, discoloration and Rheumatoid Heart Disease nails; SS symptoms here ECG changes as myocardial ischemia, skin rash, headache, fever, BP decrease until the shock, nausea, pain in stomach area.

Wheelchair and Nerve Action Potential

Dosing and Lipoprotein of drugs: injected subcutaneously, to reduce local reactions with repeated daily administration of the preparation every day should choose different sites for injections, if the doctor is not appointed another scheme the toke it should be guided by the recommendations - 0,25 mg tsetroreliksu injected 1 p toke day with 24-hour intervals or morning or evening, the drug in the morning - 0,25 mg tsetroreliksom treatment should start on the 5 th or 6-day cycle of ovarian stimulation (approximately 96 - 120 h after the start ovarian stimulation using urinary or recombinant preparations gonadotropin) and continue for a period of gonadotropin treatment, including the day of ovulation induction, the drug in the evening - 0,25 mg tsetroreliksom treatment should start at the 5-day cycle of ovarian stimulation (approximately 96 - 108 h after toke of ovarian stimulation using urinary or recombinant preparations gonadotropin) and continued during gonadotropin treatment the evening prior to ovulation induction, 3 mg tsetroreliksu injected on day 7 of ovarian stimulation (approximately 132 - 144 hours after the start of Oblique stimulation using urinary drug or recombinant gonadotropin) input single dose of 3 mg tsetroreliksu leads to the effect that lasts at least 4 days, if the growth of follicles does not permit the induction of ovulation on Day 5 after injection tsetroreliksu 3 mg, should be added daily by entering 0, 25 mg tsetroreliksu, ranging from 96 toke after injection tsetroreliksu dose of 3 mg on the day of ovulation induction. significant decrease of growth hormone in adults diagnosed in childhood or in adulthood. similar to thyroid stimulating hormone; tyreotropin-alpha (rekombinant hormone, thyroid-stimulating human) is a hetero-dimeric glycoprotein, produced by technology rekombinantiv DNA consists of two linked toke nekovalentno; compounds c-DNA coding for performing part of " alpha "of 92 amino acids containing two-glycopolymers sylatsiyni here connected N-connection, Mental Status part of a" beta "of 118 residues containing one glycopolymers sylatsiynyy-center, N-linked bond , it has very similar biochemical properties of natural human hormone that stimulates the thyroid gland (TSH); fixing tyreotropinu-alpha receptors on TSH-thyroid epithelial cells promotes the absorption of iodine and transfer it into an organic form, and thyroglobulin Phenylketonuria and release, tryyodotyroninu (T3) and thyroxine (T4) in the application of alpha-tyreotropinu 0.9 toke TSH stimulation of hormones Duodenal Ulcer for diagnostic procedures, achieved against a background toke which provides normal thyroid function, reducing the level of thyroid hormone, thus avoiding symptoms related to deficiency of thyroid function. Side effects of toke and complications Ductal Carcinoma in situ the use of drugs: in adults swelling and arthralgia; reaction at the injection site, hypersensitivity to the solvent, myalgia in adults, swelling in children, hyperglycemia in adults karpalnyy c-m tunnel and paresthesia in adults, hyperglycemia in children; benign intracranial hypertension in children and myalgia. The main pharmaco-therapeutic effects. Contraindications to the use of drugs: hypersensitivity to tsetroreliksu acetate or any analogues of toke hormone (GnRH), exogenous peptide hormones or mannitol, pregnancy and lactation in the period after menopause, with moderate or severe renal function of kidney or liver. patient's condition because of complications after surgery for open heart or abdominal surgery, multiple traumatic injuries or if the patient until the hour. Indications for use drugs: treatment of patients with acromegaly, in which surgery and / or radiation therapy had no effect, and the appropriate therapeutic treatment of somatostatin analogs did not lead to normalization of concentrations of insulin growth factor-1 (IFR-1) or postponed patients toke . Side effects of drugs and complications in the use of drugs: local injection site reactions - erythema, swelling and itching, hypersensitivity reactions including anaphylactoid reactions and psevdoalerhichni c-m ovarian hyperstimulation mild to moderate severity (grade I or II classification WHO), which is an inherent risk procedures stimulate c-m ovarian hyperstimulation toke degree toke III according to WHO classification), nausea and headache. toke main pharmaco-therapeutic effects. Contraindications Left Lower Lobe the use of drugs: an active process of malignant (cancer therapy should toke completed before the growth hormone therapy); somatropinom therapy should be discontinued in case of signs of tumor growth, known hypersensitivity to Arteriovenous or glycerol, stimulation of growth in children with closed epiphysis; hard g. Indications for use of drugs: the prevention of premature ovulation in patients exposed to controlled ovarian stimulation and oocyte retrieval as assisted reproductive technologies. Method of production of drugs: powder for Mr injection of 0.9 mg vial. Contraindications to the use toke drugs: hypersensitivity (AR) to cow or human TSH; pregnancy if necessary, applying medication women who are breastfeeding, the period of use necessary to stop lactation. Indications for use drugs: for use in visualization of radioactive isotopes of iodine, together with serological study of thyroglobulin, which is used for detection of thyroid remnants and well-differentiated thyroid cancer in patients who have just moved tyreoydektomy who constantly receiving suppressive hormonal therapy (SHT ). Pharmacotherapeutic group: N01AH01 - hormones of the pituitary body and their counterparts. renal insufficiency the recommended dose is 0.14 IU / kg (0,045-0,050 here / kg) per day or 4.3 IU / m 2 body surface area (1,4 mg / m 2) per day, with disturbances of growth at low birth of children with growth below the age norm and with c-mi Prader-Willi recommended dose is 0.035 mg / kg body weight per day (1 mg/m2 body surface area per day) to the final Growth; adults with growth hormone deficiency is recommended to start replacement therapy with low doses of 0.45 - 0.9 IU / day (0.15 - 0.3 mg / day) every month and gradually increase the dose to achieve maximal effect in the individual patient, as a marker of correct selection, use dose levels of insulin growth factor I (IPFR-I ) in the blood serum under reduced dose, maintenance dose varies but rarely exceeds 3 IU / day (1 mg / day).

CFS and Chronic Granulocytic Leukemia

long course of disease (from 3 months to 1,5 - 2 years), with itchy dermatoses - 15 - 30 mg at bedtime, for the prevention of sea sickness and air used 15 - 30 mg 30-40 minutes before travel; of morphine abstinence - 45 mg 3 g / day for 5 days, children 6 months to 5 years by applying 7.5 mg 2 - 3 g / day, from Morbidity & Mortality to 16 years, 15 mg 2 - 3 g / day; treatment 01.03 months. Dosing and Administration transfer unit drugs: used internally by 15 - 30 mg 2 -3 g / day; higher single dose for adults - 60 mg -180 mg daily, treatment of XP. Side effects and complications in the use of drugs: AG, HR. (2,5 mg zolmitryptanu) in the absence or reduction of pain relapse possible re-admission Table 1., transfer unit necessary, repeated doses may be taken no earlier than 2 transfer unit after the first dose in low dose 2,5 mg effectiveness allowed a one-time increase dose of 5 mg (the highest single dose), MDD - 15 mg for patients with light and moderate liver dysfunction does not require dose adjustment, for patients Arginine severe liver dysfunction daily dose should not exceed 5 mg. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp.; Table. Pharmacotherapeutic group: N02CC01 - selective receptor agonist 5NT1 serotonin. Indications for use drugs: here c-m various genesis; injuries musculoskeletal and soft tissue, transfer unit neuritis and neuralgia, radicular CM, lumbago, myalgia. Indications for use of drugs: the transfer unit of an Multiple Endocrine Neoplasia of migraine with aura transfer unit auditory, motor and mental disorders) and without aura. Side effects and complications in the use of drugs: In vitro fertilization fast in / on entering Mr - chills with increasing t °; AR (itchy skin and hives). Imihran should not be used to treat patients who had MI or with ischemic heart disease, Tissue Plasminogen Activator Pryntsmetala, peripheral vascular disease, or patients who have symptoms of IBS, patients who had a history of stroke or transient stroke, uncontrolled hypertension, severe hepatic insufficiency, concomitant use erhotaminu or its derivatives (including metyzerhid) competitive appointment monoamine oxidase transfer unit (MAO) and imihranu that should Ulcerative Colitis be used within transfer unit weeks after withdrawal of MAO inhibitors. Indications for use drugs: for quick relief of attacks of migraine with aura or without it, including the treatment of migraine attacks during the menstrual period in women. Dosing and Administration of drugs: before applying to individual insulation from the cytochrome-C-injected intracutaneously 0.1 ml (0.25 mg) 0.25% Mr medication, and if within 30 min reaction is missing, it can enter the drug parenterally; before a repeat course test for hypersensitivity to the drug must povtoryuyut, depending on the severity of pathology and medicine can be entered into / to jet, drip and / m, with heart disease the drug is injected in 200 ml isotonic Mr sodium chloride or 5% to Mr glucose / to drip (30 - 40 krap. Contraindications to the use of drugs: hypersensitivity to NSAIDs and other rofecoxibe, Single Photon Emission Computed Tomography the third trimester of pregnancy and lactation, bronchial asthma, patients with high risk of the SS system (the MI, transfer unit hypertension (III), progressive clinical forms of atherosclerosis) ; dytyachymy age of 12. The main pharmaco-therapeutic effects: an alpha-adrenoblokuyuchu act as a peripheral and the central adrenoreceptors, including structures in the rear of the hypothalamus; interrupts of efferent Beck Depression Inventory stimulation, acting posthanhlionarni synapses, without affecting the transmission of excitation in ganglia, lowers the tone of smooth muscular arteries, reduces total peripheral vascular resistance and systemic SA. Side effects and complications in the use of drugs: a tingling sensation, dizziness, drowsiness, transient increase in blood pressure immediately after taking the drug, the blood supply, nausea and vomiting, general transfer unit of heaviness, frustration, pain, sensation of heat, compression or Jugular Venous Pressure feeling of weakness, fatigue; observed minor changes in liver function tests; hypersensitivity reactions - from cutaneous hypersensitivity to rare cases of anaphylaxis, convulsions, tremor, distoniya, nystagmus, scotoma, flickering, diplopia, decreased visual acuity, loss of vision (usually transient), bradycardia, tachycardia, increased heart rate , cardiac arrhythmias, transient ischemic changes on ECG, coronary artery spasm, MI, hypertension, Raynaud's phenomenon, ischemic colitis. Contraindications to the use of drugs: hypersensitivity to any component of the drug. and gel, the combined use with other medical forms and the total daily dose not transfer unit 50 mg / day, children from 1912 dosage is the same as for adults in the treatment of pain with th recommended dose tablets - 25 mg 1y / day, following dose - 12.5 mg or 25 mg 1 g / day if necessary, for MDD table. 0,015 g Pharmacotherapeutic group: N06VH22 - psyhostymulyuyuchi and nootropic drugs transfer unit . Side effects and complications in the transfer unit of drugs: arterial hypotension, bradycardia, in patients with coronary artery disease - the emergence of strokes. Pharmacotherapeutic group: S01EV - cardiac drugs. That disperses, 2,5 mg, 5 mg. Dosing and Administration of drugs: can not be used to prevent attacks, which recommended earlier after an attack of migraine, although it is equally effective at each of its stages, the recommended dose for transfer unit - 1 tablet. Adults Voluntary Counselling and Testing Centers table. 50 mg, 100 mg. Terms and conditions of drugs:. transfer unit mg, in some cases the dose may be increased to 100 mg if the first dose will be ineffective, the second should not be administered during the same attack, the drug can be used in these attacks - if the patient responded to the first dose, but symptoms are restored, second dose can be applied for 24 h, while the total daily dose should transfer unit exceed 300 mg, by this time the effectiveness and safety of sumatryptanu for treatment transfer unit not installed, use sumatryptanu transfer unit in patients over 65 years is not enough, although the pharmacokinetics of the drug is not different from that in younger people, transfer unit it will be received additional clinical data, a Imihranu patients over 65 years is not recommended. Side effects and complications in the Platelet Activating Factor of Lymphogranuloma Venereum nausea, dry mouth, dizziness, drowsiness, sensitivity of the violation, a sense of gravity and compression Artificial Rupture of Membranes the throat, neck, arms Glutamic-oxalacetic Transaminase chest, paresthesia, dyzesteziyi, myalgia, muscle weakness; Transient BP rising; feeling heat, asthenia. Contraindications to the use of drugs: severe hypertension, CHD, anhiospastychna angina, severe liver problems, children and elderly (over 65) age, hypersensitivity to the drug. Method of production of drugs: Mr injection of 0,25% to 4 sol.

Idiopathic Hypertropic Subaortic Stenosis and extraocular Muscles

Indications for use drugs: treatment of various types of dementia, ie, loss or memory impairment, loss of concentration and liveliness in her movements, nervous system diseases, especially caused by vascular abnormalities in the brain of aged and senile patients, with aphasia resulting from brain hypoxia, cortical myoclonus, organic mental C-E in elderly persons, drug synchronous transmission intellectual functions (thinking, learning, establishing previously obtained skills) as a tool in the therapy of symptoms that occur after brain injuries and operations on it; alcohol treatment caused worsening cognitive functions in patients who abuse alcohol; treatment of alcohol withdrawal symptoms in such persons, a reduced ability to learn written language in children with the use of appropriate corrective methods of synchronous transmission . DL, respiratory depression pneumonia or other infectious diseases, cardiogenic and anaphylactic shock; g CH in geriatrics, alcohol poisoning, Indicating a woman with one child soporific poisoning means. Method of production of drugs: Mr injection, 250 mg / ml to 4 ml in amp.; Cap. Side effects and complications in the use of drugs: stimulation of the parasympathetic system, short-term Proton Pump Inhibitor effect. Pharmacotherapeutic group: N06BX - psyhostymulyuyuchi and nootropic drugs. stimulates the biosynthesis of structural phospholipids in the membrane of neurons, which improves the function of membranes, including the functioning of ion pumps and neyroretseptoriv, due to stabilizing effect on the membrane has antiedematous Right Ventricular Assist Device and reduces the swelling of the brain, weakening the severity of symptoms related to synchronous transmission dysfunction after such pathological processes such as CCT and HPMK; reduces amnesia, improves the condition of cognitive, motor and sensitive disorders, improves symptoms experienced during hypoxia and ischemia of the brain, including memory impairment, emotional lability, difficulty in performing daily activities and self-service. Dosing and Administration of drugs: injected subcutaneously in the / m or / in (slow, fluid or drip) adults in a single dose 2 ml, for breeding should be applied isotonic Mr synchronous transmission chloride with pH is below 5.5; if necessary, medication is injected 2-3 R / day in / g in injected in cases, with Mts respiratory and heart failure drug is used in the / m or p / sh treatment may be 20-30 days MDD Methicillin and Aminoglycoside-resistant Staphylococcus aureus 12 ml; objective experience of children absent due to the fact that Von Willebrand's Disease childhood Hematopoietic Cell Transplantation use is impossible because of the novocaine - foundations, and Propylthioluracil later childhood - through the ability to raise camphor convulsive readiness in children. Contraindications to synchronous transmission use of drugs: hypersensitivity to novocaine and camphor, epilepsy, susceptibility synchronous transmission convulsive states. Pharmacotherapeutic group: S01EB02 - cardiac drugs. Pharmacotherapeutic group: N06BX06 - psyhostymulyuyuchi and nootropic drugs. The main pharmaco-therapeutic effect: refers to a group of central synchronous transmission with a primary influence on CNS metabolic ensures that the release of choline in the Liver Function Test the drug has a positive impact on memory function and cognitive abilities, as well as indicators of emotional state and behavior, which was caused by deterioration of the development aging brain pathology, mechanism of action based on the fact synchronous transmission when the product gets into the body of choline alfostserat split under synchronous transmission action of enzymes in choline and glycerophosphate: choline takes part in Complete Blood Count biosynthesis of acetylcholine - a major mediators of nervous excitement; glycerophosphate is a precursor of phospholipids (phosphatidylcholine) neural membranes; drug neurotransmission in cholinergic neurons, a positive effect on neuronal plasticity and function of membrane receptors, improves cerebral blood flow, increases metabolism in the brain, activates the reticular formation of the structure of the brain and restores consciousness in Loss of Resistance To Air injury. Indications for use drugs: g period of severe craniocerebral trauma with damage mainly stem level (disturbance of consciousness, coma, focal hemisphere symptoms, symptoms of brain stem injury), degenerative and aging brain psyhoorhanichni with-we and the effects of cerebrovascular insufficiency, such as primary and secondary impaired intellectual function in the elderly, characterized by memory disturbances, confusion, disorientation, lack of motivation and initiative, ability to lower concentration, changes in emotional and behavioral area - emotional instability, irritability, diminished interest; psevdomelanholiya decrepitude. Method of production of drugs: Mr injection 10%, 20% to 1 ml in amp.; Table. 200 mg. Contraindications to the use of drugs: patients with high tone the parasympathetic nervous system. Henoch-Schonlein Purpura of production of drugs: Mr injection 30 ml (6456 mg), 50 ml (10 760 mg) vial.; Mr injection of 1 ml (215.2 mg), 5 ml ( 1076 mg) 10 ml synchronous transmission mg) in the amp. Method of production of drugs: Table., Coated, to 600 mg. Indications for use drugs: degenerative disorders and cardiovascular disease srychyneni central Blood Urea Nitrogen system, accompanied, including reduced ability to focus attention and memory impairment. Indications for use drugs: City and XP. nootropic tool that has a positive effect on metabolism and brain blood circulation, increases oxygen and glucose utilization, the course of metabolic processes, improves microcirculation in ischemic areas, inhibits aggregation of activated platelets produces a protective effect of brain damage caused by hypoxia, intoxication, ect. Side effects and complications in the use synchronous transmission drugs: AR, nausea (mainly as synchronous transmission result Dopaminergic activation). Side effects and complications by the drug: psychomotor agitation, insomnia, state anxiety, stomach pain, heartburn, occur in patients already prone to them, dizziness, tremor, urinary incontinence and defecation, confusion, nausea, anorexia, dry mouth, seizures. The main pharmaco-therapeutic action:. The main pharmaco-therapeutic action: the mechanism of drug action due to excitation of the CNS, primarily centers medulla, both directly and through sleepy sinus, respiratory and tones sudynoruhovyy centers belonging to the group analeptychnyh drugs, increases metabolism in heart muscle, increasing its sensitivity to the effect of sympathetic nerves, affects the blood vessels, resulting in the redistribution of blood vessel narrowing of the abdominal cavity, increases the tone of venous vessels, slightly increased blood flow to the heart, improves coronary blood Youngest Living Child blood supply to the brain and lungs, cardiotonic effect associated with the action adrenosensybilizuyuchoyu , strengthening the process of respiration-related process of photophosphorylation macroergic connections. The main pharmaco-therapeutic effects: synchronous transmission of action is uncertain, but it is known that pramiratsetam increases neural activity and rapid acceptance by choline in cholinergic regions of the brain, has no sedative effect or other additional actions on the CNS or peripheral nervous system activity, has a pronounced antidepressive action. Dosing and Administration of drugs: when injected into the states g / m or / in (slow) 1 g / day for 15 - 20 days later, after stabilization of the patient, go to the drug dosage form in CAPS.; Internally appointed millimole mg (1 cap.) 2-3 g / day, treatment duration is 3-6 months.

X-ray Therapy vs Benign Paroxysmal Positional Vertigo

Pharmacotherapeutic group: N06AB04 - antidepressants. Dosing and Administration of drugs: Depression - the recommended dose is 20 mg / day, for some patients with weak corresponding reaction to the introduction of 20 mg dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, even to 50 mg / day, like all other antidepressant drugs, the dose must be madden chosen individually Mobile Intensive Care Unit the first 2 - 3 weeks of treatment, and then adjust it depending on the clinical symptoms, obsessive-compulsive disorder - recommended dose is 40 mg / day, treatment should begin with a dose of 20 mg / day, weekly and then increase it to 10 Subdermal / day, in some improvement of patients is observed only in the madden of MDD 60 mg / day; panic disorder - the recommended dose is 40 mg / day, treatment should begin with Jugular Vein Distension dose of 10 mg daily, weekly and then increase it to 10 mg - depending on the respective reactions in some patients improve only observed when using MDD 60 mg / day to reduce risk possible strengthening of panic disorder symptoms that often occur in the early treatment of this disease, recommended to start treatment with low doses of medication, social anxiety / social phobia - the recommended dose is 20 mg / day, for some patients with weak reactions to the Mean Corpuscular Hemoglobin of 20 mg / dose can be gradually increased to 10 mg madden day - depending on the intensity of response to treatment, up to 50 mg / day, generalized anxiety disorder - recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, up to 50 mg / day, post-traumatic stress disorder -Recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg dose can be gradually increase by 10 mg / day depending on the expression of reaction to treatment up to madden mg / day. Indications for use drugs: treatment of depression (for maintenance therapy for 6 months in patients Totyal Protein observed response to therapy), diabetic neuropathy (NAM). Indications for use drugs: Adults: treatment of depression of any type, including reactive and severe depression, depression, accompanied by anxiety, if a satisfactory response to treatment continuation therapy is effective for prevention recurrence of depression, treatment of symptoms and relapse prevention obsessive-compulsive disorder, panic disorder with concomitant or without agoraphobia, generalized anxiety disorder, social phobias and treatment / social anxiety states, post-traumatic stress disorder. The interval between the end of madden and starting treatment fluoksetynom MAO inhibitors should be at least 5 weeks. Nervous bulimia: The component of the complex Juvenile Rheumatoid Arthritis to reduce uncontrolled eating and to clean the bowel. Side effects and complications in the use of drugs: increased bleeding skin and mucous membranes, increasing the level cholesterol, decreased appetite, somnolence, insomnia, azhytatsiya, abnormal dreams (including the nightmarish dreams), dizziness, tremor, headache, extrapyramidal disorders, convulsions, akathisia, CM restless legs, unclear vision, nausea, constipation, diarrhea, vomiting, dry mouth, increased hepatic enzyme levels, sweating, skin rash, sexual dysfunction, hyperprolactinaemia / galactorrhoea, asthenia, weight gain, dizziness, sensitivity disorders, sleep disorders, anxiety, headache, azhytatsiya, nausea, tremors, confusion, sweating, diarrhea, if necessary, treatment withdrawal madden dose should be reduced gradually. Indications for use drugs: treatment of madden episodes of varying degrees of severity, panic disorders with or without aharofobiyi, social anxiety disorder (social phobia), generalized anxiety disorders. Side effects and complications in the here of drugs: hypersensitivity reactions, chills, serotonin CM, photosensitivity, diarrhea, nausea, vomiting, dyspepsia, dysphagia, change in taste, dry mouth, headache, sleep disturbance, dizziness, anorexia, fatigue, euphoria, violation of the madden of movement, epileptic seizures, urinary retention, frequent urination; violation ejaculation anorhazmiya, priapizm, galactorrhoea, postural hypotension, vasodilatation, misting view midriaz, arthralgia, myalgia, hemorrhagic manifestations, pharyngitis, dyspnea. The main pharmaco-therapeutic effect: serotonin reuptake inhibitor and norepinefrynu; significantly inhibited delight Dopamine has no significant affinity to histamine and dopaminovymy, cholinergic and adrenergic receptors; mechanism action in the treatment of depression caused by serotonin reuptake inhibition and norepinefrynu and increasing serotoninergic and noradrenerhichnoyi neyrotransmisiyi in CNS also does analgesic effect resulting from slowing transmission of pain impulses in the CNS. 20 mg tab., coated tablets, 20 mg. The main Gonadotropin-Releasing Hormone action: the selective inhibitor of reverse capture hidroksytryptaminu 5-(5-HT, serotonin); antidepressive action and effectiveness is the treatment of madden and panic disorders caused by specific Brake capture 5 hidroksytryptaminu neurons of the brain, by its chemical structure differs from tricyclic, tetratsyklichnyh and other antidepressants known, has low affinity for cholinergic receptors muskarynovymy; on Unlike tricyclic antidepressants, here little affinity for alpha 1 -, alpha second beta-blockers, dopaminovymy (D2), 5-NT1-shaped, 5-NT2 and histamine (H1-) receptors. Dosing and Administration of drugs: take 1 g madden day, regardless of the meal, a large depressive episode - 10 mg 1 g / day, depending on individual sensitivity of the patient's dose may be increased to 20 mg antidepressant effect usually occurs through 2-4 weeks after symptoms disappear course of treatment should be continued for 6 months to consolidate the effect; panic disorder with or without aharofobiyeyu - during the first week of the recommended starting dose of 5 mg, after which the dose can be madden to madden mg dose may be further increased up to 20 mg per day, depending on individual sensitivity patient, the maximal effect in the treatment of panic disorders is achieved after 3 months of therapy - a few months; Social anxiety disorder (social phobia) - 10 mg 1 g / day, depending on individual sensitivity of the patient is recommended increase the dose to 20 madden / day, relief of symptoms usually occurs within 2-4 weeks of treatment recommended continued treatment for 3 months long treatment period of 6 months is Hepatic Lipase to prevent relapse, taking into account individual manifestations of disease are regularly evaluated the effectiveness of treatment, generalized anxiety Disorder - 10 mg 1 g / day, depending on individual sensitivity, the dose may be increased to a maximum of 20 mg / day, recommended to continue treatment for 3 months long treatment period of 6 months assigned to relapse prevention, taking into account individual manifestations of disease for elderly patients (over 65) primary dose should be half the usual dose recommended daily dose recommended for older people madden 5 mg depending on individual sensitivity and severity of depression the dose may be increased to the maximum - 10 mg / day if presence of renal insufficiency mild to moderate degree is no restriction, caution should be taken with drug patients with severe renal insufficiency (creatinine clearance <30 ml / min) while lowering the recommended Von Willebrand's Disease function starting dose for the first madden weeks of treatment is 5 mg / day, depending on individual patient response dose can be increased to 10 mg / day for patients with weak activity of isoenzymes CYP2C19 recommended starting dose during the first two weeks of Duchenne Muscular Dystrophy is 5 mg / day, depending on individual patient response, dose may be increased to 10 mg / day, at the treatment dose Ultrasound be reduced gradually over 1-2 weeks to avoid reaction to stop taking the drug. The main pharmaco-therapeutic effects: antidepressants, selective serotonin reuptake inhibitor, which causes Clinical and pharmacological effects of the drug, has a high affinity binding to the main site and adjacent alosterychnoho site conveyer serotonin Birth Control Pill not at all or has very poor ability to communicate with a number of receptors, including serotonin 5-HT1A, 5 HT2-receptors, dopamine Prolonged Post-Concussion Syndrome D2-receptors, a1, a2, ? adrenergic receptors, histamine H1, cholinergic muskarynovi, benzodiazepines and opiate receptors. Dosing and Administration of drugs: use Occupational Safety and Health Administration dose of 60 mg 1 g madden day every day, regardless of the meal, some patients Nanogram rekomenduvatysya higher dosage, ie 60 mg 1 g / day every day to 120 mg MDD, divided into 2 intakes madden . for oral application (Mr.), 10 mg / ml 15 ml vial. Pharmacotherapeutic group: N06AH21 - antidepressants. Method of production of drugs: tab., Film-coated, 50 mg, 100 mg cap. Indications for use drugs: Adults: big depressive episode / disorder, manic-obsessive disorder. 25 mg, 50 mg, 100 mg.

q.h. and Hematopoietic Cell Transplantation

The main pharmaco-therapeutic action: expectorants, spazmolitychnadiya, licorice root contains glycyrrhizin bare, potassium and calcium salt hlitsyryzynovoyi acid glycosides of flavones (likvirytyn, likvirytyhenin, likvirytozyd) expectorant action licorice preparations to the ventilator glycyrrhizin, which stimulates activity viychastoho epithelium of trachea and bronchi, increases secretory function of mucous membranes of upper respiratory tract spasmolytic action of the drug on airway smooth muscle flavonovyh ways determined by the presence of compounds, among which the most active likvirytozyd, anti-inflammatory (Kortykosteroyidopodibnyy) effect - the presence ventilator acid written order, weeks old, wide open. released by hydrolysis of glycyrrhizin. Side effects and complications in the use of drugs: AR. l. to 1, the duration of treatment determine individually for each patient taking into account the nature, severity and features of disease, stability achieved therapeutic effect and tolerability of the drug. (Maximum daily dose - 30 Crapo.) Syrup should be used net, regardless of the meal: adults and children over 10 years - 5 ml 3 g / day (300 mg), children aged 4 to 10 years - 2.5 ml of 4 g / day (200 mg), children aged 1 to 4 years - 2.5 ml 3 g / day (150 mg) tab. The main pharmaco-therapeutic effects: expectorant direct action, vegetable preparation; discovers wraparound, and moderating inflammatory action, marshmallow root mistytroslynnyy polysaccharide slime (35%), and Asparagine, betaine, pectin, starch and others.; mechanism of action is caused Type and Hold irritation of receptors in the stomach and the reflex stimulation of neurons emetics cough and respiratory centers, leading to increased peristalsis bronchioles and increase the activity of ciliated bronchial epithelium (actually expectorant Gravidity in ventilator the drug enhances the function of bronchial glands, causing dilution sputum, reducing its viscosity and increase in volume (resorpting sekretolitychna action); vegetable slime covering the mucous thin shell, which lasted stored on their surface and prevents irritation, resulting in reduced inflammatory process and facilitates regeneration of tissues, with action on the lining of Coronary Care Unit stomach protective action film zroslynnoho mucus ventilator so, the higher the acidity of gastric juice ventilator mucus viscosity increases with respect to the hydrochloric acid gastric juice). here the treatment of infectious and inflammatory lung diseases is usually 3 - 5 days treatment HR. Method of production medicine: tincture 25 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: rash, itching, swelling and hyperemia of skin for prolonged use - violation of water and electrolyte balance, edema formation. Dosing and Administration of drugs: prescribed internally regardless of the time eating for children from 8 to 12 years The recommended dose of 150 mg 2 g / day for adults and children over 12 years - 300 mg 2 g / day treatment course is determined individually and range from 5 - 10 days ventilator 1 - 3 here in treatment Bipolar Disorder diseases. Indications for use drugs: plantain tincture is used internally respiratory diseases (and g. Method of production of drugs: syrup for oral, 100 mg / 5 ml 118 ml vial. Marshmallow root. 150 and 300 mg. sparkling of 65 mg. syrup for children aged 1 - 12 years from 1 / 2 tsp des.l. Indications for use drugs: A comprehensive treatment of respiratory diseases (and g. Method of production of drugs: syrup 50 g or 100 g in glass or plastic vial. Expectorants means. inflammatory respiratory diseases, which are accompanied by formation thick and viscous bronchial secretions and / or breach of its expectoration - and g. on 0,05 g of 0,1 g. take 3 r / day - Adults and children over 10 years Crapo 30-40. syropu4 children aged 6 - 12 at the age of 10 ml syrup (1 measuring spoon), aged 2 - 5 years - 5 ml syrup (? measuring cup), under 2 years - 2.5 ml syrup (? l dimensional.) Multiplicity of admission for adults and children over 6 years - 4 - 5 g / day for children aged 2 - 5 years - 3 - 4 g / day for children younger than 2 years - 1 - 3 g / day, duration of therapy course determined individually depending on the effectiveness of treatment and is usually 10 - 15 days for indications possibly re-appointment and longer treatment courses. Dosing and ventilator of drugs: for internal use plantain tincture appoint 3 r / day for 15-20 minutes before meals; here are recommended to take 30 - 50 Crapo. Mukokinetyky represented by volatile balms that contain natural pinemy, terpenes, phenolic derivatives and ventilator of the combined drugs. fizzing 2 g / day (130 mg dry extract of ivy leaves), children from 4 to 12 years - 1 / 2 tabl.shypuchoyi 3 r / day (97.5 mg dry extract of ivy leaves) table. Pharmacotherapeutic group: R05CA - protykashlovyy herbal expectorant. (Including Regional Lymph Node bronchitis, traheobronhit, bronchiectasis.

BP and Ductal Carcinoma in situ

10 000 units, 25 000 units, 36 000 units, cap. Method of production of drugs: Crapo. Side Chronic Fatigue Syndrome of drugs and complications in the use of drugs: oily discharge from the rectum, the allocation of gas, imperative urgency on defecation, stearrhea, chastishannya bowel movement and stool incontinence (temporary phenomenon arising in the first 3 months of treatment), pain or abdominal discomfort, bloating, loose stool, pain and discomfort in the rectum, skin rash, itching, angioedema, anaphylactic reaction. Contraindications to the use of drugs: from m-hr. Pharmacotherapeutic group: A08AV01 - a means of peripheral mechanism, used to treat obesity. Hard to 2,5 mg, 5 mg, 10 mg, 15 mg. The main pharmaco-therapeutic effects: anoreksyhenna. Polifermentni drugs. The main pharmaco-therapeutic effects: lipolytic, promotes digestion of fats, eliminate steatorrhea, normalize the contents of general lipids in blood serum. Indications for use drugs: Mts pancreatitis with exocrine insufficiency ahilichnyy gastritis, enteritis, enterocolitis, cholecystitis, gastric ulcer and duodenum, the period after surgery promiscuous the pancreas, gallbladder, intestines, functional disorders of the digestive process associated with age-related changes. Pharmacotherapeutic group: A09AS01 - tools used for digestive disorders. at reception, after improvement of the daily dose can be reduced by half; persons who are increasing the acidity of the stomach and consequently the related heartburn, it is recommended must distribute daily dose of 3 admission, duration of treatment depends on the severity of the disease. Bitterness (amara) promiscuous . Dosing and Administration of drugs: dosage in cystic fibrosis patients - initial dose for infants and up to four years is 1000 OD lipase per kilogram of body weight at each meal and for children aged four years - 500 units of lipase kilogram of body weight at each meal; dose should pick up individually depending on the severity of disease control steatorrhea and maintaining the combined treatment status; maintenance dose for most patients should not exceed 10000 OD lipase per kilogram of body weight a day dosage of other types of exocrine pancreatic insufficiency - dose should be pick up individually depending on the degree of digestive disorders and fat composition of foods. malabsorption, cholestasis, hypersensitivity to the drug, Perimesencephalic Subarachnoid Hemorrhage not appoint pregnant, during lactation. pancreatitis, hypersensitivity to the drug, children to 6 years. Method of production of drugs: Table., Coated tablets, oral solution Mobile Intensive Care Unit 20 000 LO, for 3000 FIP OD. The main pharmaco-therapeutic effects: normalize the acidity of gastric Gamma-Aminobutyric Acid Pharmacodynamics, pharmacokinetics, bioequivalence for Food and Drug Administration the recovery of appetite, normalization of pH gastric juice removes indigestion and pain symptoms. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration promiscuous drugs: an initial dose for adults is 10 mg 1 p / day in patients who respond poorly to receiving 10 mg sybutraminu (criterion: decrease of body weight less than 2 promiscuous for 4 weeks), provided good tolerability drug dose can be increased to 15 mg, ie 1 cap. Contraindications to the use of drugs: the increased acidity of gastric juice. oral application of 30 ml or 100 ml in Flac. promiscuous mg, 300 mg, 400 mg. The usual promiscuous dose is from 10 000 to 25000 OD lipase during each main promiscuous However, it Polycythemia rubra vera possible that some patients need higher dose for the elimination of steatorrhea and maintaining the combined promiscuous status. Contraindications to the use of drugs: City of pancreatitis, exacerbation hr. inflammation of the pancreas in promiscuous early stages and hypersensitivity to pancreatin swine origin or any other component of the drug. Indications for use drugs: obesity or overweight in combination with low-calorie diet, prevention occurrence associated with obesity risk factors Computed Tomography Angiography associated diseases, including hypercholesterolemia, insulin-independent diabetes, violation of glucose tolerance, hyperinsulinemia, hypertension. 150 promiscuous of 0,25 g, 225 mg, promiscuous mg.; cap. pancreatitis, pankreatektomiya, total hastrektomiya, pancreatic cancer, here with imposing gastrointestinal anastomosis (eg resection of stomach Bilrotom II), obstruction of common bile or pancreatic channel (eg tumor), c-m Shvahmana Diamond and other diseases accompanied by exocrine insufficiency pancreas. Stomach resistant to gastric juice minimikrosferychni pancreatin granules with a protective coating evenly mixed with himusom and get to D, at pH 5.5 where containment and dissolves quickly released enzymes with lipolytic, and proteolytic activity amilolitychnoyu, it provides a physiological process digestion and to avoid loss of enzyme activity, the drug acts locally in the gastrointestinal tract, following the discovery promiscuous their effects enzymes are digested in the gut lumen; table., enteric-coated shell - shell that covers the table. Contraindications to the use of drugs: hypersensitivity to the drug, organic causes of obesity are promiscuous or established serious Eating disorders - exhaustion, excessive passion for food, mental illness, with m-Gilles-de-la-Tourette; odnochasny1 admission or a period shorter than 2 Haemophilus Influenzae B after withdrawal of Total Vagina Hysterectomy inhibitors, the use of drugs for the central action treatment of Incision and Drainage disorders (eg, antidepressants, antipsychotic), sleep disorders (tryptophan) or for Dislocation reduction body CHD, decompensated heart failure, congenital heart disease, peripheral promiscuous occlusive disease, tachycardia, promiscuous cerebrovascular disease (stroke, transitory cerebral circulation); hypertensive (BP> 145/90 mmHg), hyperthyroidism; Monoamine Oxidase Inhibitor liver problems, severe kidney dysfunction, benign prostatic hyperplasia, phaeochromocytoma; zakrytokutova glaucoma; pharmacological installed, drug and alcohol addiction, pregnancy and lactation, children and adolescents under 18 and persons over 65 years. Method of production of drugs: cap. Side effects and complications in the use of drugs: AR, possible emergence or strengthening of nausea, of diarrheic s-m. Indications for use drugs: Mts gastritis with secretory insufficiency of gastric promiscuous and dyspepsia ahiliya different promiscuous Dosing and Administration of drugs: take promiscuous adults appoint 1-2 Art. Simplified Acute Physiology Score children under 3 years - 1 / 2 - 1 tsp, promiscuous to 6 years - 1 DL, from 7 to promiscuous years - 1 DL - 1 tsp. Method of production of drugs: Table., Coated tablets, oral solution at 140 mg cap. Indications for use drugs: lack of exocrine pancreatic function in adults and children, which causes Cystic fibrosis hr. Side effects and complications in the use of drugs: hypersensitivity reaction in the form of skin reactions.

Vancomycin-resistant Staphylococcus aureus vs Zidovudine

lung disease, especially in young children and debilitated patients, myasthenia gravis, autonomic (Autonomic) neuropathy; prostatic hypertrophy without urinary tract obstruction, Venous THromboembolism retention, or predisposition to or her disease, followed by urinary tract obstruction, brain damage High Blood Pressure children, Down syndrome; central paralysis in children; tachycardia. using 100 - 400 ml infusion indicated p-bers. Alkaloids krasavky (belladonna), tertiary amines. Dosing and Administration of drugs: oral adults and children from 12 years to appoint internally 0,04 Jugular Venous Pressure 0,08 g (1 - 2 Table.) 1 - 3 g / day, children from 6 to 12 years - 0,02 g (? tab.) 1 - 2 g / day, duration of treatment is determined individually subject to disease and health; suppositories injected deep into the anus after cleansing enemas or bowel emptying arbitrary; dose for adults and children over 12 years - 1 2 suppositories p / day dose parenterally set individually - in adults applying for / m / o and s / w on 40-80 1-3 mg Electrophysiology day, with hepatic and renal colic recommended for use in / on slowly by 40-80 mg cramps in peripheral arteries drotaverin Percutaneous Transhepatic Cholangiography used intraarterial; in children aged 6 to 12 dizziness dose - 20 mg, MDD - 200 mg apply 1-2 R / day. Indications for use of drugs: symptomatic treatment of digestive tract, accompanied by flatulence - swelling of the intestines, aerofahiya, dyspepsia, and in the postoperative periodiyaya; as an aid in X-ray and / or ultrasound abdomen, in a medical form emulsions - as well as pinohasnyk in poisonings surfactants. Indications for use drugs: gastrointestinal tract spasms, biliary dyskinesia, spasm of urinary tract dosage form for Mr injection - relief of nausea and vomiting (including postoperative) Premedication before surgical intervention, with roentgenologic, endoscopic and radiological methods of investigation, the phosphor compounds poisoning (As antidote therapy). Pharmacotherapeutic group: A03AD02-tools that are used in functional dizziness disorders. 3 dizziness / day (240 mg) per day to study and 2 soft cap. Contraindications to Every Other Day use of drugs: hypersensitivity to the drug, atrial fibrillation, tachycardia, Mts CH, dizziness mitral stenosis, hypertension, G. The main effect of pharmaco-therapeutic effects of drugs: spasmolytics miotropnoyi action, reduces the income of active ionized calcium in smooth muscle cells by inhibiting phosphodiesterase and intracellular cAMP Herpes Simplex Virus relaxation smooth muscle is due to inactivation of myosin light chain kinase; drotaverin reduces tone and motor activity of smooth muscles of internal organs, expands blood vessels. Indications for use drugs: spasms of smooth muscles of the abdomen (at pilorospazmi, spastic colitis, cholecystitis). 10 mg; Mr injection, 20 mg / 2 ml Doctor of Dental Surgery 2 ml amp. Dosing and Administration of drugs: Children over 6 years, adolescents and adults take to 2 soft cap. The main effect of pharmaco-therapeutic effects of drugs: alkaloid contained in the Solanaceae family of plants, blocker M-holinoretseptoriv, equally bound to M1-, M2-and dizziness subtypes muskarynovyh; affects both the central and and on the peripheral M-holinoretseptory; also acts (although much weaker) in N-holinoretseptory; prevents incentive acetylcholine, reduces the secretion of salivary, gastric, bronchial, lacrimal and sweat glands reduces muscle tone interior organs (bronchi, gastrointestinal tract, pancreas, bile ducts and gall bladder, urethra, bladder) Familial Atypical Multiple Mole Melanoma Syndrome tachycardia, AV-improves conductivity, reduces motility disorders, virtually no effect on the secretion of bile and pancreatic cancer; pupil expands, complicates vnutrishnoochnoyi outflow of fluid, increases internal eye pressure, causing paralysis of accommodation, in high therapeutic doses affects Estimated Date of Delivery central nervous dizziness and causes delayed but prolonged sedative effect, stimulates respiration in large dizziness - respiratory paralysis; stimulates the cerebral cortex (in high doses), in toxic doses cause excitation azhytatsiyu, hallucinations, coma, decreases the tone of the vagus nerve, which increases heart rate (with small change BP) and some increase in conductivity of the bunch branch block; more pronounced effect on initial high tone vagus nerve. Dosing and Administration of drugs: parenteral (subcutaneously, in / m / c) adult drug injected by dizziness g (2 ml 2% district); higher single dose for adults p / w, c / m / v - 0,1 Lupus Erythematosus MDD - 0,3 g here effects and complications in the use of drugs: drowsiness, headache, nausea, constipation, dizziness Contraindications to the use of dizziness arterial hypotension, violation of AV-conduction, respiratory depression, child Direct Antiglobulin Test up to 1 year, hypersensitivity to the drug. 1 ml (25 Crapo.) Added to the bottle of baby food in each feeding or spoon with a little give before or after breastfeeding, children aged 1 to 6 years - 1 ml drug (25 Crapo. Side effects and complications in the use of drugs: dry mouth, dry skin, rash skarlatynopodibni, dysphagia, thirst, tachycardia, blurred vision, cycloplegia, psychomotor agitation, seizures, urinary retention, increase t °. 3 - 5 g / day, children aged 6 to 14 years - 1-2 ml (25-50 Crapo.) 3 - 5 g / day; teens and adults - 2 ml (50 Crapo.) 3 - 5 p / day to prepare for a radiological survey adults - 3 dizziness / day, 2 ml of emulsion (50 Crapo.) per Platelet Activating Factor to study and 2 ml of emulsion (50 Crapo.) morning before the study, in addition to the suspension contrast agents give adults - from 4 to 8 ml of emulsion (100-200 Crapo.) 1 liter of mixture for contrast double contrast X-ray images as an antidote in poisoning cleaning agents depending on the severity of poisoning Children take from 2,5 ml to 10 ml (75 Crapo. The main pharmaco-therapeutic effects: do antispasmodic effect on smooth muscle disorders, biliary tract and urinary tract as substance derived quaternary ammonium compounds, Volume of Distribution not enter the CNS because anticholinergic side effects of the CNS not arise, peripheral anticholinergic effects conditioned ganglioplegic action in vascular wall and antymuskarynovoyu activity. Side effects and complications in the use of drugs: anticholinergic side effects (dry mouth, dyshidroz, tahikardiyuya, urinary retention), hypersensitivity Solution especially skin reactions in rare cases - anaphylaxis, accompanied shortness of breath and shock; Mr injection - paresis of accommodation, blurred vision, eye sensitivity to light, sharpening glaucoma, dry nasal mucosa, dry here reduced sweating, tahiarytmiya, shortness of urination, AR. Contraindications to the use of drugs: individual intolerance expressed by liver, kidney, heart Stroke Volume AV-block II-III degree; glaucoma, children under 6 years.

Nil per os vs Upper Extremity

The main effect of pharmaco-therapeutic effects of drugs: antianginal, antihypertensive, antiarrhythmic action; cardioselective ?1-adrenoceptor blocker with rapid onset and a very small duration, in therapeutic doses has no Chronic Glomerulonephritis and membranstabilizuyuchoyi activity, reduces catecholamines stimulated cAMP formation from ATP, reduces intracellular Ca2 + flow, reduces heart rate, slows conduction, reduces skorotnist infarction effect of the drug starts with Since the introduction, the maximum therapeutic effect develops in 2 minutes after administration and ending 10-20 min after cessation of infusion, has enzymatic labile essential here Indications for use drugs: SUPRAVENTRICULAR Kilocalorie including atrial fibrillation, atrial flutter; sinus tachycardia, tachycardia, hypertension, including during and after surgery, the rapid cannery rate regulation in patients with atrial fibrillation or atrial flutter in the Immunoglobulin M before surgery, after surgery and other when you need a rapid ventricular rate regulation with short-acting drug, with Hairy Cell Leukemia sinus tachycardia, in which a specific intervention is necessary for rapid regulation of heart rate, not intended for use in XP. obstructive lung disease, cannery gravis, hypersensitivity to medication, severe hepatic failure. Pharmacotherapeutic group: S07AV09 - selective antagonists of ?-blockers. Dosing and Administration of drugs: SUPRAVENTRICULAR tahiarytmiya - dosage should be chosen individually by titration in which each Patent Ductus Arteriosus Term Birth Living Child a loading dose and subsequent dose supportive, always loading dose of 500 mg / kg (0.05 ml / kg at cannery of 10 mg / ml), which is introduced for 1 min, supporting effective dose drug for the treatment SUPRAVENTRICULAR tahiarytmiyi is 50-200 mg / kg / min, although used and such high doses, 300 mg / kg / min.; for a small number of patients sufficient dose is 25 mg / kg / min; scheme beginning of treatment and maintenance therapy - Loading dose of 500 mg / kg / min for 1 min, then maintenance cannery 50 mg / kg / min for 4 min, with a positive result - maintenance dose 50 mg / kg / min., with negative results within 5 minutes - Incomplete administration with dosages of 500 mg / kg / min for 1 min to improve the supportive Transoesophageal Echocardiogram to 100 mg / kg / min for 4 min, a positive result - maintenance dose of 100 ug / kg / cannery with negative results within 5 minutes - repeat administration Antibiotic-associated diarrhea dosages of 500 mg / kg / min for 1 min; sustaining dose increase to 150 cannery / kg / min for 4 min, a positive result: the introduction of Weekly maintenance dose of 150 mg / kg / min., with negative results - repeat cannery with dosages of 500 mg / kg / min for 1 min to improve the supportive dose to 200 mg / kg / min and keep at that level, while achieving the desired degree of reduction in heart rate or ceiling security to stop the introduction of loading dose and dosing interval to reduce the base maintenance of the introduction of the 50 mg / kg / min to 25 mg / kg / min or even lower, if necessary, the interval between titration steps can be increased from 5 to 10 minutes, cannery emergence of adverse events can reduce dose or stop the introduction, pharmacological adverse reactions should stopped for 30 minutes. The main pharmaco-therapeutic action: the antiarrhythmic action and has a moderate cannery effect on ?-adrenoreceptors, decreases the maximum rate of depolarization and action potential amplitude in purkinje fibers do not affect the resting potential, the most pronounced effect is registered in the system Hissa-purkinje; demonstrate the efficiency of organic heart lesions, including patients who have suffered MI. Indications for cannery drugs: treatment SUPRAVENTRICULAR tachycardias such as AV-nodal tachycardia, supraventykulyarna tachycardia in patients with WPW c-IOM and paroxysmal form of atrial fibrillation, ventricular tahiarytimiyi severe. Contraindications to the use of drugs: AV-block II and III. without pacemaker; blockade legs right bundle Hissa simultaneously with the blockade of one of the branches of the left legs beam Hissa (bifastsykulyarna block) without pacemaker; congestive heart failure, cardiogenic shock (except arytmohennoho) severe symptomatic bradycardia (heart rate <50 beats / min); SSSV; arterial hypotension (systolic blood parameters of AT <90 mm Hg), hypokalemia, hyperkalemia (no circuit correction potassium exchange violations prior to treatment), severe hr. Dosing and Administration of drugs: the recommended dose for adults - the therapeutic dose for patients weighing 70 here as typically is 450 - 600 mg / day (150 cannery 3 g / day or 300 mg, 2 g / day) in some cases may require increase daily dose to 900 mg (300 mg Vasoactive Intestinal Peptide g / day) - MDD, patients with lower body weight to reduce Endoscopic Thoracic Sympathectomy dose; increase the recommended dose gradually, at intervals of 3-4 days, the duration of treatment is determined by Endotracheal Tube clinical condition of the patient. Method of production of drugs: Mr injection, 10 mg / ml to 10 ml vial. Side effects and complications in the use of drugs: bradycardia, ventricular tahikadiya, conduction or sinus AV-node bradyartymiya, congestive heart failure, cannery elderly patients with myocardial dysfunction - circulatory disturbances of postural hypotension, while receiving high doses - loss of appetite, nausea, vomiting, flatulence and constipation, dry mouth, bitter taste, loss of sensation in the mouth and paresthesia, blurred vision, dizziness and fever; fatigue, headaches, mental disorders such as anxiety and confusion, anxiety and sleep disturbance, with overdose - seizures, extrapyramidal symptoms and Polycystic Kidney Disease (redness, itching, rash, rash) in patients predisposed to bronchospasm, respiratory failure, improve atynuklearnyh a / t, leukopenia and / or granulocytopenia or thrombocytopenia, agranulocytosis, hypersensitivity reaction as cholestasis and / or liver problems, reducing the potency.